Undeclared pre-exposure or post-exposure prophylaxis (PrEP/PEP) use among syphilis-positive blood donors, England, 2020 to 2021.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
03 2023
Historique:
entrez: 17 3 2023
pubmed: 18 3 2023
medline: 21 3 2023
Statut: ppublish

Résumé

An individualised blood donor selection policy was implemented in the United Kingdom from summer 2021. We have investigated the impact of this policy by comparing the extent of undeclared use of HIV pre-exposure or post-exposure prophylaxis (PrEP/PEP) before and after this change. The rate of PrEP usage in syphilis-positive male blood donors has not changed since individualised donor assessment was implemented but provides continuing evidence of undisclosed PrEP use which may be associated with current or past higher-risk sexual behaviours.

Identifiants

pubmed: 36927721
doi: 10.2807/1560-7917.ES.2023.28.11.2300135
pmc: PMC10021473
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Trials. 2020 Oct 30;21(1):900
pubmed: 33121503
Sex Transm Infect. 2022 Mar;98(2):132-135
pubmed: 33782147
Vox Sang. 2019 Aug;114(6):628-630
pubmed: 31106848
PLoS One. 2022 Oct 19;17(10):e0276209
pubmed: 36260550
J Acquir Immune Defic Syndr. 2017 Dec 1;76(4):e104-e106
pubmed: 29076941
Clin Infect Dis. 2016 Aug 15;63(4):555-61
pubmed: 27317797
Sex Transm Infect. 2022 Jun;98(4):293-297
pubmed: 34380778
Blood. 2020 Sep 10;136(11):1351-1358
pubmed: 32645148
J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):275-81
pubmed: 23274933
J Int AIDS Soc. 2019 Dec;22(12):e25419
pubmed: 31850686
HIV Med. 2021 Feb;22(2):75-82
pubmed: 33140556
Euro Surveill. 2019 Nov;24(48):
pubmed: 31796157

Auteurs

Victoria Maddox (V)

Microbiology Services, NHS Blood and Transplant, London, United Kingdom.

Claire Reynolds (C)

NHS Blood and Transplant/UK Health Security Agency Epidemiology Unit, NHS Blood and Transplant, London, United Kingdom.

Alieu Amara (A)

Department of Pharmacology, University of Liverpool, Liverpool, United Kingdom.

Laura Else (L)

Department of Pharmacology, University of Liverpool, Liverpool, United Kingdom.

Susan R Brailsford (SR)

Microbiology Services, NHS Blood and Transplant, London, United Kingdom.
NHS Blood and Transplant/UK Health Security Agency Epidemiology Unit, NHS Blood and Transplant, London, United Kingdom.
National Infection Service, United Kingdom Health Security Agency, London, United Kingdom.

Saye Khoo (S)

Department of Pharmacology, University of Liverpool, Liverpool, United Kingdom.

Heli Harvala (H)

Microbiology Services, NHS Blood and Transplant, London, United Kingdom.
Infection and Immunity, University College London, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH